Meeting of the Advisory Committee on Heritable Disorders in Newborns and Children, 1519 [2021-00095]

Download as PDF Federal Register / Vol. 86, No. 5 / Friday, January 8, 2021 / Notices recommendations regarding inclusion of additional conditions for screening, following adoption by the Secretary, are Health Resources and Services evidence-informed preventive health Administration services provided for in the comprehensive guidelines supported by Meeting of the Advisory Committee on HRSA through the Recommended Heritable Disorders in Newborns and Uniform Screening Panel (RUSP) Children pursuant to section 2713 of the PHS Act (42 U.S.C. 300gg-13). Under this AGENCY: Health Resources and Services provision, non-grandfathered group Administration (HRSA), Department of health plans and health insurance Health and Human Services (HHS). issuers offering group or individual ACTION: Notice. health insurance are required to provide insurance coverage without cost-sharing SUMMARY: In accordance with section (a co-payment, co-insurance, or 1111(g) of the Public Health Service deductible) for preventive services for (PHS) Act, and the Federal Advisory plan years (i.e., policy years) beginning Committee Act, this notice announces on or after the date that is one year from that the Advisory Committee on the Secretary’s adoption of the Heritable Disorders in Newborns and condition for screening. Children (ACHDNC or Committee) has During the February 11–12, 2021, scheduled a public meeting to be held meeting, ACHDNC will hear from on Thursday, February 11, 2021, and experts in the fields of public health, Friday, February 12, 2021. Information medicine, heritable disorders, rare about the ACHDNC and the agenda for disorders, and newborn screening. this meeting can be found on the Agenda items include the following: ACHDNC website at https:// (1) A presentation on potential www.hrsa.gov/advisory-committees/ processes for reviewing conditions on heritable-disorders/index.html. the RUSP; DATES: Thursday, February 11, 2021, (2) Potential revisions to the condition 10:00 a.m.–3:00 p.m. Eastern Time (ET), nomination form; and Friday, February 12, 2021, 10:00 (3) Continuity of operations planning a.m.–2:00 p.m. ET. (within the context of COVID–19); ADDRESSES: This meeting will be held (4) Innovations in long-term follow-up via webinar. While this meeting is open for conditions identified through to the public, advance registration is newborn screening; and, (5) Workgroup updates. required. Please visit the ACHDNC The agenda for this meeting does not website for information on registration: include any plans for recommending a https://www.hrsa.gov/advisorycondition for inclusion in the RUSP. committees/heritable-disorders/ index.html. The deadline for registration Agenda items are subject to change as priorities dictate. Information about the is 12:00 p.m. ET on February 10, 2021. ACHDNC, including a roster of members Instructions for accessing the meeting and past meeting summaries, are also via webcast will be provided upon available on the ACHDNC website. registration. Members of the public also will have FOR FURTHER INFORMATION CONTACT: the opportunity to provide comments. Alaina Harris, Maternal and Child Public participants may submit written Health Bureau, HRSA, 5600 Fishers statements in advance of the scheduled Lane, Room 18W66, Rockville, meeting. Oral comments will be taken in Maryland 20857; 301–443–0721; or the order they are requested and may be ACHDNC@hrsa.gov. limited as time allows. Requests to SUPPLEMENTARY INFORMATION: ACHDNC provide a written statement or make oral provides advice and recommendations comments to the ACHDNC must be to the Secretary of HHS (Secretary) on submitted via the registration website by the development of newborn screening Friday, February 5, 2021, at 12:00 p.m. activities, technologies, policies, ET. guidelines, and programs for effectively Individuals who need special reducing morbidity and mortality in assistance or another reasonable newborns and children having, or at risk accommodation should notify Alaina for, heritable disorders. The ACHDNC Harris at the address and phone number reviews and reports regularly on listed above at least 10 business days newborn and childhood screening prior to the meeting. practices, recommends improvements in Maria G. Button, the national newborn and childhood Director, Executive Secretariat. screening programs, and fulfills [FR Doc. 2021–00095 Filed 1–7–21; 8:45 am] requirements stated in the authorizing legislation. In addition, ACHDNC’s BILLING CODE 4165–15–P tkelley on DSKBCP9HB2PROD with NOTICES DEPARTMENT OF HEALTH AND HUMAN SERVICES VerDate Sep<11>2014 21:23 Jan 07, 2021 Jkt 253001 PO 00000 Frm 00045 Fmt 4703 Sfmt 9990 1519 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute on Alcohol Abuse and Alcoholism; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute on Alcohol Abuse and Alcoholism Special Emphasis Panel; NIAAA Review Subcommittee Member Conflict Applications. Date: March 3, 2021. Time: 2:00 p.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institute of Health, National Institute on Alcohol Abuse and Alcoholism, 6700 B Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Luis Espinoza, Ph.D., Scientific Review Officer, Extramural Project Review Branch, Office of Extramural Activities, National Institute on Alcohol Abuse and Alcoholism, 6700B Rockledge Drive, Room 2109, Bethesda, MD 20892, (301) 443–8599, espinozala@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.271, Alcohol Research Career Development Awards for Scientists and Clinicians; 93.272, Alcohol National Research Service Awards for Research Training; 93.273, Alcohol Research Programs; 93.891, Alcohol Research Center Grants; 93.701, ARRA Related Biomedical Research and Research Support Awards, National Institutes of Health, HHS) Dated: January 4, 2021. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2021–00087 Filed 1–7–21; 8:45 am] BILLING CODE 4140–01–P E:\FR\FM\08JAN1.SGM 08JAN1

Agencies

[Federal Register Volume 86, Number 5 (Friday, January 8, 2021)]
[Notices]
[Page 1519]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-00095]



[[Page 1519]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


Meeting of the Advisory Committee on Heritable Disorders in 
Newborns and Children

AGENCY: Health Resources and Services Administration (HRSA), Department 
of Health and Human Services (HHS).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In accordance with section 1111(g) of the Public Health 
Service (PHS) Act, and the Federal Advisory Committee Act, this notice 
announces that the Advisory Committee on Heritable Disorders in 
Newborns and Children (ACHDNC or Committee) has scheduled a public 
meeting to be held on Thursday, February 11, 2021, and Friday, February 
12, 2021. Information about the ACHDNC and the agenda for this meeting 
can be found on the ACHDNC website at https://www.hrsa.gov/advisory-committees/heritable-disorders/index.html.

DATES: Thursday, February 11, 2021, 10:00 a.m.-3:00 p.m. Eastern Time 
(ET), and Friday, February 12, 2021, 10:00 a.m.-2:00 p.m. ET.

ADDRESSES: This meeting will be held via webinar. While this meeting is 
open to the public, advance registration is required. Please visit the 
ACHDNC website for information on registration: https://www.hrsa.gov/advisory-committees/heritable-disorders/index.html. The deadline for 
registration is 12:00 p.m. ET on February 10, 2021. Instructions for 
accessing the meeting via webcast will be provided upon registration.

FOR FURTHER INFORMATION CONTACT: Alaina Harris, Maternal and Child 
Health Bureau, HRSA, 5600 Fishers Lane, Room 18W66, Rockville, Maryland 
20857; 301-443-0721; or [email protected].

SUPPLEMENTARY INFORMATION: ACHDNC provides advice and recommendations 
to the Secretary of HHS (Secretary) on the development of newborn 
screening activities, technologies, policies, guidelines, and programs 
for effectively reducing morbidity and mortality in newborns and 
children having, or at risk for, heritable disorders. The ACHDNC 
reviews and reports regularly on newborn and childhood screening 
practices, recommends improvements in the national newborn and 
childhood screening programs, and fulfills requirements stated in the 
authorizing legislation. In addition, ACHDNC's recommendations 
regarding inclusion of additional conditions for screening, following 
adoption by the Secretary, are evidence-informed preventive health 
services provided for in the comprehensive guidelines supported by HRSA 
through the Recommended Uniform Screening Panel (RUSP) pursuant to 
section 2713 of the PHS Act (42 U.S.C. 300gg-13). Under this provision, 
non-grandfathered group health plans and health insurance issuers 
offering group or individual health insurance are required to provide 
insurance coverage without cost-sharing (a co-payment, co-insurance, or 
deductible) for preventive services for plan years (i.e., policy years) 
beginning on or after the date that is one year from the Secretary's 
adoption of the condition for screening.
    During the February 11-12, 2021, meeting, ACHDNC will hear from 
experts in the fields of public health, medicine, heritable disorders, 
rare disorders, and newborn screening. Agenda items include the 
following:
    (1) A presentation on potential processes for reviewing conditions 
on the RUSP;
    (2) Potential revisions to the condition nomination form;
    (3) Continuity of operations planning (within the context of COVID-
19);
    (4) Innovations in long-term follow-up for conditions identified 
through newborn screening; and,
    (5) Workgroup updates.
    The agenda for this meeting does not include any plans for 
recommending a condition for inclusion in the RUSP. Agenda items are 
subject to change as priorities dictate. Information about the ACHDNC, 
including a roster of members and past meeting summaries, are also 
available on the ACHDNC website.
    Members of the public also will have the opportunity to provide 
comments. Public participants may submit written statements in advance 
of the scheduled meeting. Oral comments will be taken in the order they 
are requested and may be limited as time allows. Requests to provide a 
written statement or make oral comments to the ACHDNC must be submitted 
via the registration website by Friday, February 5, 2021, at 12:00 p.m. 
ET.
    Individuals who need special assistance or another reasonable 
accommodation should notify Alaina Harris at the address and phone 
number listed above at least 10 business days prior to the meeting.

Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2021-00095 Filed 1-7-21; 8:45 am]
BILLING CODE 4165-15-P